Antibiotics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Antibiotics Market, By Action Mechanism

7.1.  Antibiotics Market, By Action Mechanism Type, 2020-2030

7.1.1.    Cell Wall Synthesis Inhibitors

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Protein Synthesis Inhibitors

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    DNA Synthesis Inhibitors

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    RNA Synthesis Inhibitors

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Mycolic Acid Inhibitors

7.1.5.1.        Market Revenue and Forecast (2016-2030)

7.1.6.    Others

7.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Antibiotics Market, By Drug Class

8.1.  Antibiotics Market, By Drug Class, 2020-2030

8.1.1.    Cephalosporin

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Penicillin

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Fluoroquinolone

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Macrolide

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Carbapenem

8.1.5.1.        Market Revenue and Forecast (2016-2030)

8.1.6.    Aminoglycoside

8.1.6.1.        Market Revenue and Forecast (2016-2030)

8.1.7.    Sulfonamide

8.1.7.1.        Market Revenue and Forecast (2016-2030)

8.1.8.    7-ACA

8.1.8.1.        Market Revenue and Forecast (2016-2030)

8.1.9.    Others

8.1.9.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Antibiotics Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.1.2.    Market Revenue and Forecast, By Drug Class (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.1.3.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.1.4.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.2.2.    Market Revenue and Forecast, By Drug Class (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.2.3.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.2.4.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.2.5.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.2.6.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.3.2.    Market Revenue and Forecast, By Drug Class (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.3.3.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.3.4.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.3.5.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.3.6.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.4.2.    Market Revenue and Forecast, By Drug Class (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.4.3.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.4.4.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.4.5.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.4.6.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.5.2.    Market Revenue and Forecast, By Drug Class (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.5.3.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Action Mechanism (2016-2030)

9.5.4.2.        Market Revenue and Forecast, By Drug Class (2016-2030)

Chapter 10.  Company Profiles

10.1.              Merck & Co., Inc.

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Allergan plc (AbbVie)

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              GlaxoSmithKline plc.

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Pfizer Inc.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Melinta Therapeutics

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Basilea Pharmaceutica Ltd.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Tetraphase Pharmaceuticals

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Paratek Pharmaceuticals, Inc.

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Nabriva Therapeutics plc

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Spero Therapeutics

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms